Apyx Medical Corp — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2019-08-01

Reporting Person: Waldman Lawrence (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Stock Option (Option to Buy)	$7.28	A	17000	Acquired	2029-08-01	Common Stock (17000.0)	Direct

Footnotes

F1: Reporting person was granted a stock option in accordance with director compensation plan which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.